BRTX BioRestorative Therapies, Inc.: institutional ownership and insider trading
21 funds reported holding $1.14M of BioRestorative Therapies, Inc. in their latest 13F filings; in Q2 2026 funds net bought $748K, with 10 new positions and 0 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market; over its last four quarters it reported revenue of $358K and net income of −$11.1M.
BRTX revenue and earnings
- Quarter ended Mar 31, 2026: revenue $23.2K, net income −$2.15M, EPS -0.12
- Quarter ended Dec 31, 2025: revenue $19.6K, net income −$3.21M, EPS -0.31
- Quarter ended Sep 30, 2025: revenue $11.8K, net income −$3.04M, EPS -0.33
- Quarter ended Jun 30, 2025: revenue $303K, net income −$2.66M, EPS -0.30
Famous investors holding BRTX
- Ken Griffin (Citadel Advisors): $103K, 0.0% of the portfolio
Largest institutional holders of BRTX
- JANE STREET GROUP, LLC — $302K
- HRT FINANCIAL LP — $267K
- XTX Topco Ltd — $108K
- VANGUARD GROUP INC — $104K
- CITADEL ADVISORS LLC — $103K
- VANGUARD FIDUCIARY TRUST CO — $68.2K
- GEODE CAPITAL MANAGEMENT, LLC — $57.3K
- US FINANCIAL ADVISORS, LLC — $30.5K
- CITIGROUP INC (C, C-PN) — $24.0K
- WEALTH ALLIANCE, LLC — $15.0K
Recent BRTX insider trades
- Oct 28, 2024: Broadrick Dale sold 1,112 shares ($1.76K)
5%+ owners
- Auctus Fund, LLC: 9.9% (Schedule 13G/A, filed May 15, 2026)
Who owns the most BRTX stock?
The largest institutional holders of BioRestorative Therapies, Inc. in the latest 13F filings are JANE STREET GROUP, LLC ($302K), HRT FINANCIAL LP ($267K), XTX Topco Ltd ($108K).
Are insiders buying or selling BRTX?
No open-market insider buys or sells of BioRestorative Therapies, Inc. were reported in the last 12 months.
Which famous investors own BRTX?
Ken Griffin.
What was BRTX's revenue last quarter?
BioRestorative Therapies, Inc. reported revenue of $23.2K for the quarter ended March 31, 2026, with net income of −$2.15M.